The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis
- PMID: 32502242
- PMCID: PMC7531906
- DOI: 10.1210/clinem/dgaa348
The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis
Abstract
Objective: We set forth to compare ethnicities for metabolic and immunological characteristics at the clinical diagnosis of type 1 diabetes (T1D) and assess the effect of ethnicity on beta-cell functional loss within 3 years after clinical diagnosis.
Research methods and design: We studied participants in TrialNet New Onset Intervention Trials (n = 624, median age = 14.4 years, 58% male, 8.7% Hispanic) and followed them prospectively for 3 years. Mixed meal tolerance tests (MMTT) were performed within 6 months following clinical diagnosis and repeated semiannually. Unless otherwise indicated, analyses were adjusted for age, sex, BMI Z-score, and diabetes duration.
Results: At T1D clinical diagnosis, Hispanics, compared with non-Hispanic whites (NHW), had a higher frequency of diabetic ketoacidosis (DKA) (44.7% vs 25.3%, OR = 2.36, P = 0.01), lower fasting glucose (97 vs 109 mg/dL, P = 0.02) and higher fasting C-peptide (1.23 vs 0.94 ng/mL, P = 0.02) on the first MMTT, and higher frequency of ZnT8 autoantibody positivity (n = 201, 94.1% vs 64%, OR = 7.98, P = 0.05). After exclusion of participants in experimental arms of positive clinical trials, C-peptide area under the curve (AUC) trajectories during the first 3 years after clinical diagnosis were not significantly different between Hispanics and NHW after adjusting for age, sex, BMI-z score, and DKA (n = 413, P = 0.14).
Conclusion: Despite differences in the metabolic and immunological characteristics at clinical diagnosis of T1D between Hispanics and NHW, C-peptide trajectories did not differ significantly in the first 3 years following clinical diagnosis after adjustment for body mass index and other confounders. These findings may inform the design of observational studies and intervention trials in T1D.
Keywords: C-peptide; Hispanics; beta-cell function; ethnic minorities; ethnicity; type 1 diabetes.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Broadening Our Understanding Type 1 Diabetes Heterogeneity by Exploring Effects of Race/Ethnicity on Disease Trajectory.J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4961-3. doi: 10.1210/clinem/dgaa375. J Clin Endocrinol Metab. 2020. PMID: 32542394 Free PMC article. No abstract available.
Similar articles
-
Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.J Clin Endocrinol Metab. 2020 May 1;105(5):1629-40. doi: 10.1210/clinem/dgz296. J Clin Endocrinol Metab. 2020. PMID: 31867614 Free PMC article.
-
Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes.Pediatr Diabetes. 2012 Nov;13(7):564-71. doi: 10.1111/j.1399-5448.2012.00875.x. Epub 2012 May 30. Pediatr Diabetes. 2012. PMID: 22642603
-
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors.Diabetes Care. 2018 May;41(5):1017-1024. doi: 10.2337/dc17-2335. Epub 2018 Mar 1. Diabetes Care. 2018. PMID: 29496742
-
Heterogeneity of Type 1 Diabetes: The Effect of Ethnicity.Curr Diabetes Rev. 2018;14(3):266-272. doi: 10.2174/1573399813666170502105402. Curr Diabetes Rev. 2018. PMID: 28464767 Review.
-
Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables.Diabetologia. 2019 Jan;62(1):33-40. doi: 10.1007/s00125-018-4722-z. Epub 2018 Aug 30. Diabetologia. 2019. PMID: 30167735 Free PMC article. Review.
Cited by
-
Broadening Our Understanding Type 1 Diabetes Heterogeneity by Exploring Effects of Race/Ethnicity on Disease Trajectory.J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4961-3. doi: 10.1210/clinem/dgaa375. J Clin Endocrinol Metab. 2020. PMID: 32542394 Free PMC article. No abstract available.
-
Endocrine Health and Health Care Disparities in the Pediatric and Sexual and Gender Minority Populations: An Endocrine Society Scientific Statement.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1533-1584. doi: 10.1210/clinem/dgad124. J Clin Endocrinol Metab. 2023. PMID: 37191578 Free PMC article.
-
Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy.Diabetol Metab Syndr. 2023 Mar 20;15(1):51. doi: 10.1186/s13098-023-01014-z. Diabetol Metab Syndr. 2023. PMID: 36935525 Free PMC article.
-
Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.J Clin Endocrinol Metab. 2025 Mar 17;110(4):1187-1194. doi: 10.1210/clinem/dgae608. J Clin Endocrinol Metab. 2025. PMID: 39231249 Free PMC article.
References
-
- Gandhi K, Tosur M, Schaub R, Haymond MW, Redondo MJ. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017;34(10):1435-1439. - PubMed
-
- The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med. 1998;128(7):517-523. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK085476/DK/NIDDK NIH HHS/United States
- U01 DK061010/DK/NIDDK NIH HHS/United States
- U01 DK085453/DK/NIDDK NIH HHS/United States
- U01 DK103282/DK/NIDDK NIH HHS/United States
- U01 DK061042/DK/NIDDK NIH HHS/United States
- U01 DK085509/DK/NIDDK NIH HHS/United States
- UC4 DK117009/DK/NIDDK NIH HHS/United States
- U01 DK085466/DK/NIDDK NIH HHS/United States
- U01 DK103153/DK/NIDDK NIH HHS/United States
- U01 DK061058/DK/NIDDK NIH HHS/United States
- U01 DK106984/DK/NIDDK NIH HHS/United States
- U01 DK085499/DK/NIDDK NIH HHS/United States
- U01 DK107013/DK/NIDDK NIH HHS/United States
- U01 DK103266/DK/NIDDK NIH HHS/United States
- UC4 DK106993/DK/NIDDK NIH HHS/United States
- P30 DK045735/DK/NIDDK NIH HHS/United States
- U01 DK107014/DK/NIDDK NIH HHS/United States
- U01 DK106994/DK/NIDDK NIH HHS/United States
- U01 DK061034/DK/NIDDK NIH HHS/United States
- U01 DK085461/DK/NIDDK NIH HHS/United States
- UC4 DK097835/DK/NIDDK NIH HHS/United States
- U01 DK103180/DK/NIDDK NIH HHS/United States
- U01 DK085465/DK/NIDDK NIH HHS/United States
- P30 DK020595/DK/NIDDK NIH HHS/United States
- U01 DK085504/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical